Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple step test could change how lipedema is assessed

NCT ID NCT07752017

Knowledge-focused Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study looks at whether the 2-Minute Step Test—a quick, equipment-free exercise test—can reliably measure functional capacity in women with lipedema, a chronic fat tissue disorder that affects the legs and can limit mobility. Researchers will compare the step test results with other established fitness tests and repeat the test to check its consistency. The goal is to see if this simple test can be a useful tool for evaluating and monitoring patients with lipedema.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the test proves reliable, it could offer a simple, low-cost way to track functional capacity in lipedema care.
What could go wrong
This is a small, early-stage study focused on measurement accuracy, not treatment. The test may not fully capture the condition's impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 55 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with lipedema

Ages

18 to 65 years

Sex

Female participants only

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinically diagnosed with lipedema according to the Wold and Halk-Damstra criteria, stage 2 and above * Aged 18-65 years, female * No walking-limiting pathology * Willing to participate Exclusion Criteria: * Uncontrolled hypertension * Decompensated cardiac failure * Systemic, degenerative, neurological, rheumatological, or orthopedic disease affecting lower-extremity function * Lower-extremity surgery within the past 6 months * Peripheral artery disease causing vascular claudication * Severe psychiatric disorder (active psychosis, severe major depression) or cognitive impairment preventing compliance with test instructions * Neuromuscular disease * Pregnancy * Advanced-stage lipo-lymphedema severely restricting ambulation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lipedema are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Lipedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lipedema

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.